Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services symbols : Xcur save search
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
Published: 2024-02-05 (Crawled : 23:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: 1.1%
H: 1.82%
C: 1.76%
hepatitis patent license treatment therapeutics agreement
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-11 (Crawled : 22:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -4.49%
H: 3.9%
C: 3.9%
update financial results
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-07-14 (Crawled : 23:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: 11.11%
H: 2.86%
C: -2.86%
update financial results
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
Published: 2023-04-27 (Crawled : 12:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -1.83%
H: 3.33%
C: -0.13%
ceo
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements Exicure, Inc. an early-stage biotechnology company historically focused on developing nucleic acid therapies targeting r...
Published: 2022-12-14 (Crawled : 12:00) - biospace.com/
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: 0.1%
H: 2.9%
C: 1.25%
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: 0.0%
H: 11.14%
C: 0.79%
collaboration
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
Published: 2022-12-14 (Crawled : 11:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: 0.0%
H: 11.14%
C: 0.79%
collaboration
NeuBase Abandons Huntington's, 60% of Workforce in Strategic Pivot
Published: 2022-10-17 (Crawled : 13:20) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -1.93%
H: 1.97%
C: 0.65%
NeuBase Drops Huntington's Program, Slashes 60% of Workforce
Published: 2022-10-17 (Crawled : 12:20) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -1.93%
H: 1.97%
C: 0.65%
Exicure Lays off Two-Thirds of Workforce, Suspends R&D in Restructuring
Published: 2022-09-27 (Crawled : 19:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -2.94%
H: 0.61%
C: -14.55%
Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives
Published: 2022-09-26 (Crawled : 22:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: 2.26%
H: 9.22%
C: 7.95%
agreement
Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference
Published: 2022-09-01 (Crawled : 17:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -2.73%
H: 1.69%
C: 0.56%
conference genetic presentation
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
ABBV | News | $165.97 0.8% 3.1M
|
Health Technology
|
| O: 0.36%
H: 0.12%
C: -0.57%
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -0.44%
H: 5.29%
C: 2.2%
results
Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032 | DelveInsight
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
XCUR 4 | $0.5788 19K
|
Commercial Services
| Email alert
Add to watchlist
ADAP | $1.005 11.87% 1.2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
EVLO | $0.3165 -87.39% 710K
|
Health Technology
| Email alert
Add to watchlist
LLY | $727.48 -2.48% 2M
|
Health Technology
| Email alert
Add to watchlist
cancer market prostate cancer
Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
Published: 2022-05-17 (Crawled : 12:20) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -1.92%
H: 15.55%
C: 6.8%
sciences conference presentation
Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference
Published: 2022-05-09 (Crawled : 12:20) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -4.31%
H: 0.25%
C: -16.58%
conference therapeutics
Coya Therapeutics Appoints David Snyder as Chief Financial Officer and Chief Operating Officer
Published: 2022-03-30 (Crawled : 15:20) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: 0.66%
H: 2.8%
C: -3.6%
therapeutics
Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress
Published: 2022-03-25 (Crawled : 21:00) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -0.67%
H: 0.68%
C: -16.13%
results
Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
Published: 2022-02-04 (Crawled : 13:30) - biospace.com/
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -20.82%
H: 0.0%
C: 0.0%
ces
ROSEN, LEADING INVESTOR COUNSEL, Encourages Baidu Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important February 14 Deadline in Securities Class Action - BIDU
Published: 2022-02-04 (Crawled : 03:00) - prnewswire.com
MS | News 0 d | $90.86 0.66% 4.7M
|
Finance
|
| O: -1.35%
H: 0.0%
C: 0.0%
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -20.82%
H: 0.0%
C: 0.0%
BIDU | $94.92 -0.69% 1.3M
|
Technology Services
|
| O: -0.89%
H: 0.0%
C: 0.0%
100 deadline
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Faraday Future Intelligent Electric, Inc. f/k/a Property Solutions Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FFIE, FFIEW, PSAC, PSACW, PSACU
Published: 2022-01-18 (Crawled : 01:00) - prnewswire.com
XCUR 4 | $0.5788 19K
|
Commercial Services
|
| O: -0.86%
H: 0.64%
C: 0.12%
acquisition trial intel acquisition corp deadline
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.